Patent details

EP3027598 Title: OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES

Basic Information

Publication number:
EP3027598
PCT Application Number:
EP2014001895
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147390454
PCT Publication Number:
WO2015014442
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES
French Title of Invention:
DÉRIVÉS OXOQUINAZOLINYL-BUTANAMIDE
German Title of Invention:
OXOCHINAZOLINYLBUTANAMIDDERIVATE
SPC Number:

Dates

Filing date:
10/07/2014
Grant date:
12/04/2017
EP Publication Date:
08/06/2016
PCT Publication Date:
05/02/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/04/2017
EP B1 Publication Date:
12/04/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/07/2023
Expiration date:
10/07/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/04/2017
 
 

Name:
Merck Patent GmbH
Address:
Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)

Inventor

1

Name:
DORSCH, Dieter
Address:
Germany (DE)

2

Name:
BUCHSTALLER, Hans-Peter
Address:
Germany (DE)

Priority

Priority Number:
13003815
Priority Date:
31/07/2013
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/517; A61P 9/00; A61P 25/00; A61P 35/00; C07D 401/06; C07D 401/14; C07D 413/14;

Publication

European Patent Bulletin

Issue number:
201715
Publication date:
12/04/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/06/2022
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages